Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease

European Journal of Ophthalmology

Volumn 14, Issue 5, 2004, Pages 445-448

  Giansanti, Fabrizio ^a   Barbera, M L ^a   Virgili, G ^a   Pieri, B ^a   Emmi, L ^a   Menchini, U ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Beh et disease; Infliximab; Retinal neovascularization; Uveitis

Indexed keywords

CYCLOSPORIN; INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISOLONE; RIFAMPICIN; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BEHCET DISEASE; CASE REPORT; DISEASE ASSOCIATION; EYE INFLAMMATION; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REMISSION; RETINA NEOVASCULARIZATION; TREATMENT OUTCOME; TUBERCULOSIS; UVEITIS; VISUAL ACUITY;

EID: 8344276694     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400515     Document Type: Article

References (9)

1. Sfikakis PP, Theossidiadis PG, Katsiari CG, et al. Effect of infliximab on sight-threatening panuveitis in Behçet's disease [letter]. Lancet 2001; 358: 295-6.
2. Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J, et al. Effect of infliximab on threatening panuveitis in Behçet's disease [letter]. Lancet 2001; 358: 1644.
3. Joseph A, Raj D, Dua HS, et al. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 2003; 110: 1449-53.
4. Triolo G, Vadala M, Accardo-Palumbo A, et al. Anti-tumor necrosis factor antibody treatment for ocular Behçet's disease. Ann Rheum Dis 2002; 61: 560-1.
5. Maini R, St Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 1999; 354: 1932-9.
6. Kimura SJ, Thygeson P, Hogan MJ. Signs and symptoms of uveitis. 1. Anterior uveitis. Am J Ophthalmol 1959; 47: 155-70.
7. Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985; 92: 467-71.
8. Graham EM, Stanford MR, Shilling JS, et al. Neovascularization associated with posterior uveitis. Br J Ophthalmol 1987; 71: 826-33.
9. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.